The genetic and functional basis of isolated 17,20 lyase deficiency
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Human male sexual differentiation requires production of fetal testicular testosterone, whose biosynthesis requires steroid 17,20-lyase activity. Patients with putative isolated 17,20-lyase deficiency have been reported. The existence of true isolated 17,20-lyase deficiency, however, has been questioned because 17 alpha-hydroxylase and 17,20-lyase activities are catalyzed by a single enzyme, microsomal cytochrome P450c17, and because the index case of apparent isolated 17,20-lyase deficiency had combined deficiencies of both activities. We studied two patients with clinical and hormonal findings suggestive of isolated 17,20-lyase deficiency. We found two patients homozygous for substitution mutations in CYP17, the gene encoding P450c17. When expressed in COS-1 cells, the mutants retained 17 alpha-hydroxylase activity but had minimal 17,20-lyase activity. Substrate competition experiments suggested that the mutations did not alter the enzyme's substrate-binding capacity, but co-transfection of cells with P450 oxidoreductase, the electron donor used by P450c17, indicated that the mutants had a diminished ability to interact with redox partners. Computer-graphic modelling of P450c17 suggests that both mutations lie in or near the redox-partner binding site, on the opposite side of the haem from the substrate-binding pocket. These mutations alter electrostatic charge distribution in the redox-partner binding site, so that electron transfer for the 17,20-lyase reaction is selectiv…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because both the 17␣-hydroxylase and 17,20-lyase activities of P450c17 are catalyzed on the same active site, it was not clear that a syndrome of isolated 17,20-lyase deficiency could exist until two patients with genital ambiguity, normal excretion of 17-hydroxycorticosteroids, and markedly reduced production of C 19 steroids were studied at the molecular genetic level (279).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [279]
In the citing paper
“When assayed in vitro, both mutants retained nearly normal 17␣-hydroxylase activity but had no detectable 17,20-lyase activity (279, 280),”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [279]
In the citing paper
“One patient was homozygous for the P450c17 mutation R347H, and the other was homozygous for R358Q; both mutations changed the distribution of surface charges in the redoxpartner binding site of P450c17 (279).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [279]
In the citing paper
“The model identifies Arg 347 and Arg 358 and several other arginine and lysine residues in the redox partner binding site; mutations of these residues all cause varying degrees of selective loss of 17,20lyase activity (240, 279, 280, 284).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [279]
In the citing paper
“Because the 17,20-lyase activity of P450c17 is especially sensitive to perturbations in electron transport (49, 279, 280), defects in fetal testicular steroidogenesis leading to incompletely developed external genitalia in 46,XY males is the predicted outcome.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [279]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90368-2 · Cited by 1,001
Ferrin, T. E., Huang, C. C., Jarvis, L. E., & Langridge, R. (1988) · Journal of Molecular Graphics · doi:10.1016/0263-7855(88)80054-7 · Cited by 950
Crystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450's
Ravichandran, K. G., Boddupalli, S. S., Hasermann, C. A., Peterson, J. A., & Deisenhofer, J. (1993) · Science · doi:10.1126/science.8342039 · Cited by 877
Structure and function of cytochromes P450: a comparative analysis of three crystal structures
Hasemann, C. A., Kurumbail, R. G., Boddupalli, S. S., Peterson, J. A., & Deisenhofer, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00134-4 · Cited by 692
Williams Textbook of Endocrinology
Stoffer, S. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110109043 · Cited by 608
Zhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Self-citationChung, B. C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., & Miller, W. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.407 · Cited by 444
Self-citationPICADO-LEONARD, J., & MILLER, W. L. (1987) · DNA · doi:10.1089/dna.1987.6.439 · Cited by 415
Self-citation17α-Hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition
YANASE, T., SIMPSON, E. R., & WATERMAN, M. R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-91 · Cited by 390
Research works printed but not linked: 2
- Miller, W.L. & Tyrrell, J.B. The adrenal cortex. In Endocrinology and Metabolism, 3rd ed. (eds Felig, P., Baxter, J. & Frohman, L.) 555–717 (McGraw-Hill, New York, (1995).
- Heinisch, U., Zlotogora, J., Kafert, S. & Gieselmann, V. Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am. J. Hum. Genet. 56, 51–57 (1995).
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationGenome-wide association study identifies eight loci associated with blood pressure
Wellcome Trust Case Control Consortium, Newton-Cheh, C., Johnson, T., Gateva, V., Tobin, M. D., Bochud, M., Coin, L., Najjar, S. S., Zhao, J. H., Heath, S. C., et al. (2009) · Nature Genetics · doi:10.1038/ng.361 · Cited by 1,215
“Missense mutations in CYP17A1 cause one form of adrenal hyperplasia characterized by hypertension, hypokalemia and reduced plasma renin activit”
Cytochromes P450: a success story.
Werck‐Reichhart, D., & Feyereisen, R. (2000) · Genome biology · doi:10.1186/gb-2000-1-6-reviews3003 · Cited by 1,004
“(some allelic variants) Only the 17,20-lyase activity [39]”
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citation10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationHuman cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
“Rare mutations can cause isolated 17,20-lyase deficiency, sparing the 17a-hydroxylase activity; most are found in the domain of P450c17 that interacts with POR— especially Arg347His and Arg358Gln [115,116]—although one active-site mutation, Glu305Gly, causes an equivalent phenotype [117].”
BackgroundSelf-citationSalt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association
Elijovich, F., Weinberger, M. H., Anderson, C. A. M., Appel, L. J., Bursztyn, M., Cook, N. R., Dart, R. A., Newton-Cheh, C. H., Sacks, F. M., & Laffer, C. L. (2016) · Hypertension · doi:10.1161/hyp.0000000000000047 · Cited by 482
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Self-citationArlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
“In this system, a yeast strain lacking the gene for yeast POR was transiently transfected with vectors expressing human P450c17 and POR (Auchus et al. 1998).”
BackgroundMethodInfluentialSelf-citationMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationGenetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Formation and Cleavage of C–C Bonds by Enzymatic Oxidation–Reduction Reactions
Guengerich, F. P., & Yoshimoto, F. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00031 · Cited by 296
THE GENETICS, PATHOPHYSIOLOGX, AND MANAGEMENT OF HUMAN DEFICIENCIES OF P450c17
Auchus, R. J. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70021-5 · Cited by 266
Self-citationFlück, C. E., Meyer-Böni, M., Pandey, A. V., Kempná, P., Miller, W. L., Schoenle, E. J., & Biason-Lauber, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.009 · Cited by 248
Self-citationSteroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
“Among the distinguishing laboratory features is the elevated 17OHP/AD ratio at baseline or with hCG stimulation, which is typically >50 in affected cases [18].”
Self-citationCosta-Santos, M., Kater, C. E., & Auchus, R. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031021 · Cited by 224
“ant of isolated 17,20-lyase deficiency (17, 18).”
BackgroundSelf-citationGuengerich, F. P. (2007) · Cytochrome P450 · doi:10.1007/0-387-27447-2_10 · Cited by 220
Basic concepts and recent developments in human steroid hormone biosynthesis
Ghayee, H. K., & Auchus, R. J. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9052-2 · Cited by 212
“These ILD mutations tend to interfere more with electron transfer [33] but can impair substrate binding [34].”
BackgroundSelf-citationAdrenal Corticosteroid Biosynthesis, Metabolism, and Action
Arlt, W., & Stewart, P. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.002 · Cited by 195
“encoding these enzymes result in human disease [7–13], so some understanding of the underlying pathways and steroid precursors is required.”
BackgroundInhibitors of Testosterone Biosynthetic and Metabolic Activation Enzymes
Ye, L., Su, Z.-J., & Ge, R.-S. (2011) · Molecules · doi:10.3390/molecules16129983 · Cited by 189
“masculinization that can range from partial to complete pseudohermaphroditism and breast enlargement [18,19].”
BackgroundAuchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
“tants support the model (12, 13); others have initiated”
BackgroundMethodInfluentialSelf-citationGeller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183
Self-citationAndrogen biosynthesis from cholesterol to DHEA
Miller, W. L. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00363-5 · Cited by 179
Self-citationRegulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165
Self-citationThe syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
Self-citationSteroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism
Storbeck, K.-H., Schiffer, L., Baranowski, E. S., Chortis, V., Prete, A., Barnard, L., Gilligan, L. C., Taylor, A. E., Idkowiak, J., Arlt, W., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00262 · Cited by 141
Gilep, A. A., Sushko, T. A., & Usanov, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.021 · Cited by 145
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Self-citationCongenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307586200 · Cited by 131
Self-citationAndrogen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“isolated 17,20 lyase deficiency [87, 89].”
BackgroundSelf-citationA review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)
Akhtar, M., Wright, J. N., & Lee-Robichaud, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.003 · Cited by 131
Low, T. Y., van Heesch, S., van den Toorn, H., Giansanti, P., Cristobal, A., Toonen, P., Schafer, S., Hübner, N., van Breukelen, B., Mohammed, S., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.041 · Cited by 126
“Interestingly, mutations in human CYP17A1 are known to lead to congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency, which results in hypogonadism, pseudohermaphroditism, and severe hypertension (Biglieri, 1997; Biglieri et al., 1966; Geller et al., 1997; Goldsmith et al., 1967).”
van den Akker, E. L. T., Koper, J. W., Boehmer, A. L. M., Themmen, A. P. N., Verhoef-Post, M., Timmerman, M. A., Otten, B. J., Drop, S. L. S., & De Jong, F. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011880 · Cited by 125
“Only 2 mutations identified in patients with isolated complete 17,20-lyase deficiency were examined in vitro (Table 1) (14).”
BackgroundGenetic and clinical features of P450 oxidoreductase deficiency
Scott, R. R., & Miller, W. L. (2008) · Hormone Research in Paediatrics · doi:10.1159/000114857 · Cited by 115
Self-citationIsolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
“Some microsomal 17,20-lyase activity is found even in the complete absence of CytB5; CytB5 deficiency therefore cannot cause a syndrome of complete 17,20-lyase deficiency (12).”
BackgroundMartin, R. M., Lin, C. J., Costa, E. M. F., de Oliveira, M. L., Carrilho, A., Villar, H., Longui, C. A., & Mendonca, B. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030988 · Cited by 109
Cytochromes P450: Roles in diseases
Pikuleva, I. A., & Waterman, M. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.431916 · Cited by 101
Idkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Marsh, C. A., & Auchus, R. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.011 · Cited by 103
Self-citationCytochrome b5 modulation of 17α hydroxylase and 17–20 lyase (CYP17) activities in steroidogenesis
Akhtar, M. K., Kelly, S. L., & Kaderbhai, M. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06375 · Cited by 120
“However, male patients with isolated lyase deficiency were identified with homozygous mutations for Arg347 His and Arg358 Gln, thus providing a focal point in the understanding of the lyase selectivity of CYP17 (Geller et al. 1997).”
BackgroundArlt, W., Martens, J. W. M., Song, M., Wang, J. T., Auchus, R. J., & Miller, W. L. (2002) · Endocrinology · doi:10.1210/en.2002-220456 · Cited by 101
“, Madison, WI), amplified and sequenced using primers complementary to the human sequence (21).”
BackgroundSelf-citationSubstrate-modulated Cytochrome P450 17A1 and Cytochrome b5 Interactions Revealed by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468926 · Cited by 100
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Hershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
“Genetically proven isolated 17,20-lyase deficiency was first described in two patients with point mutations in the P450c17 domain that interacts with POR; these mutations retained nearly normal 17 -hydroxylase activity but virtually no 17,20-lyase activity (11).”
BackgroundSelf-citationRole of cytochrome P450c17 in polycystic ovary syndrome
Qin, K., & Rosenfield, R. L. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00177-4 · Cited by 109
Consequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
“The 17,20 lyase activity of P450c17 is especially sensitive to perturbations in electron transport (Geller et al., 1997; Geller et al., 1999; Miller, 2005), thus affected males are hypo-androgenic.”
BackgroundSelf-citationYamaoka, M., Hara, T., & Kusaka, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0255 · Cited by 92
“For example, a clinical case of isolated congenital deficiency of 17,20-lyase activity has been reported (33), and cytochrome b5 has been reported to be necessary for 17,20-lyase activity through a non-electron transfer mechanism (34,35).”
5α-Reduced C21 steroids are substrates for human cytochrome P450c17
Gupta, M. K., Guryev, O. L., & Auchus, R. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.003 · Cited by 84
Self-citationRichter-Unruh, A., Martens, J. W. M., Verhoef‐Post, M., Wessels, H. T., Kors, W. A., Sinnecker, G. H. G., Boehmer, A. L. M., Drop, S. L. S., Toledo, S. P. A., Brunner, H. G., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01437.x · Cited by 87
Clinical, genetic and enzymatic characterization of P450 oxidoreductase deficiency in four patients
Sahakitrungruang, T., Huang, N., Tee, M. K., Agrawal, V., Russell, W. E., Crock, P., Murphy, N., Migeon, C. J., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1460 · Cited by 82
Self-citationCompagnone, N. A., Zhang, P., Vigne, J.-L., & Mellon, S. H. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.6.0469 · Cited by 81
Monogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
The molecular basis of male sexual differentiation
Hiort, O., & Holterhus, P. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420101 · Cited by 100
Scott, R. R., Gomes, L. G., Huang, N., Van Vliet, G., & Miller, W. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2345 · Cited by 79
Self-citationKim, Y., Kang, M., Choi, J., Lee, B. H., Kim, G.-H., Ohn, J. H., Kim, S. Y., Park, M. S., & Yoo, H. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.015 · Cited by 82
“[10] Geller DH, Auchus RJ, Mendonça BB, et al.”
BackgroundEarly steps in androgen biosynthesis: From cholesterol to DHEA
Miller, W. L. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80461-8 · Cited by 89
Self-citationDifferential Inhibition of CYP17A1 and CYP21A2 Activities by the P450 Oxidoreductase Mutant A287P
Dhir, V., Ivison, H. E., Krone, N., Shackleton, C. H. L., Doherty, A. J., Stewart, P. M., & Arlt, W. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0066 · Cited by 78
Miller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 82
Self-citationLin, C. J., Martens, J. W. M., & Miller, W. L. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0679 · Cited by 71
Self-citationThe next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
“Abiraterone acetate, a potent CYP17A1 inhibitor approved for use in castration-resistant prostate cancer, normalized androstenedione in adult women with classic 21OHD and elevated androgens when added to physiologic ears of congenital adrenal hyperplasia, J. Steroid Biochem.”
InfluentialSelf-citationSaenger, P. H., & DiMartino-Nardi, J. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343917 · Cited by 73
Hlavica, P., Schulze, J., & Lewis, D. F. V. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00152-1 · Cited by 80
Lam, C.-W., Arlt, W., Chan, C.-K., Honour, J. W., Lin, C. J., Tong, S.-F., Choy, K.-W., & Miller, W. L. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3134 · Cited by 65
Self-citationMonogenic Disorders of Puberty
Kalantaridou, S. N. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2481 · Cited by 65
Deletion of the Mouse P450c17 Gene Causes Early Embryonic Lethality
Bair, S. R., & Mellon, S. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5383-5390.2004 · Cited by 63
“The “Ozols peptide” (36) comprises amino acids 346 to 366 in exon 6 (39) and contains amino acids crucial for redox partner binding (5, 10, 21), so that its deletion will destroy all activity.”
BackgroundElectron Transfer Partners of Cytochrome P450
Waskell, L. A., & Kim, J. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_2 · Cited by 87
ETIOLOGICAL STUDIES OF SEVERE OR FAMILIAL HYPOSPADIAS
Boehmer, A. L. M., Nijman, R. J. M., LAMMERS, B. A. S., CONINCK, S. J. F. D., Hemel, J. O. V., Themmen, A. P. N., Mureau, M. A. M., de Jong, F. H., Brinkmann, A. O., Niermeijer, M. F., et al. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66505-6 · Cited by 64
The molecular basis of premature adrenarche: an hypothesis
Miller, W. L. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14405.x · Cited by 60
Self-citationSalvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 82
Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
Gonçalves, J., Friães, A., & Moura, L. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000300 · Cited by 60
Marohnic, C. C., Panda, S. P., Martásek, P., & Masters, B. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607095200 · Cited by 57
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Self-citationPitfalls in characterizing P450c17 mutations associated with isolated 17,20 lyase deficiency
Gupta, M. K., Geller, D. H., & Auchus, R. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7812 · Cited by 59
“COS-1 cells (18), yeast microsomes (19), and Escherichia coli”
InfluentialSelf-citationSteroid hormone synthesis in pregnancy
Kallen, C. B. (2004) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2004.08.009 · Cited by 67
“Complete deficiency of one or both enzymatic activities has been described in humans, resulting from a plethora of gene mutations and producing a wide array of phenotypes [144–147].”
BackgroundFamilial Partial 17,20-Desmolase and 17α-Hydroxylase Deficiency Presenting as Infertility
Levran, D., Ben‐Shlomo, I., Pariente, C., Dor, J., Mashiach, S., & Weissman, A. (2003) · Journal of Assisted Reproduction and Genetics · doi:10.1023/a:1021206704958 · Cited by 55
Biason-Lauber, A., Kempken, B., Werder, E., Forest, M. G., Einaudi, S., Ranke, M. B., Matsuo, N., Brunelli, V., Schönle, E. J., & Zachmann, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6475 · Cited by 55
LEE-ROBICHAUD, P., AKHTAR, M. E., & AKHTAR, M. (1998) · Biochemical Journal · doi:10.1042/bj3320293 · Cited by 54
Genetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
Self-citationLack of Defects in Androgen Production in Children with Hypospadias
Holmes, N. M., Miller, W. L., & Baskin, L. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032098 · Cited by 63
Self-citationBhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.033 · Cited by 63
Rendic, S. P., & Guengerich, F. P. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1483401 · Cited by 61
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
Miller, W. L. (2005) · Medical Principles and Practice · doi:10.1159/000086185 · Cited by 61
“No genetically and enzymologically proven cases of isolated 17,20 lyase deficiency had been reported until 1997, when we studied two patients from rural Brazil who had clinical and hormonal findings consistent with isolated 17,20 lyase deficiency [”
BackgroundSelf-citationA Practical Approach to Ambiguous Genitalia in the Newborn Period
Lambert, S. M., Vilain, E. J. N., & Kolon, T. F. (2010) · Urologic Clinics of North America · doi:10.1016/j.ucl.2010.03.014 · Cited by 50
Gonzalez, E. R., & Guengerich, F. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794917 · Cited by 53
The Physiology and Biochemistry of Adrenarche
Auchus, R. J. (2010) · Endocrine development · doi:10.1159/000321209 · Cited by 55
Self-citationThe post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“…that mutations in the redoxpartner binding site of P450c17 that reverse charge from basic to acidic (R347H, R358Q) cause 17,20-lyase deficiency (Geller et al., 1997, 1999), at least one POR mutation that changes a residue in the FMN domain from neutral to basic (G539R) has also been described…”
BackgroundSelf-citationPeng, H.-M., Im, S.-C., Pearl, N. M., Turcu, A. F., Rege, J., Waskell, L., & Auchus, R. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00532 · Cited by 50
Self-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationA Novel Point Mutation in P450c17 (CYP17) Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency
Brooke, A. M., Taylor, N., Shepherd, J. H., Gore, M. E., Ahmad, T., Lin, L., Rumsby, G., Papari-Zareei, M., Auchus, R. J., Achermann, J. C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2653 · Cited by 53
“R347H and R358Q) that change the distribution of surface charges on the redox binding site of P450c17 impair electron transfer and can result in isolated 17,20-lyase deficiency with preserved 17 hydroxylase function (8, 9, 13).”
BackgroundSelf-citationDhir, V., Reisch, N., Bleicken, C., Lebl, J., Kamrath, C., Schwarz, H., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0172 · Cited by 52
Fernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
“17OHase 17,20 lyase Normal Hyperresponsive Normal Areactive 65 5 Geller 1997 [27] Elevated Hyperresponsive Normal Areactive 65 5 Geller 1997 [27] Slightly elevated Not reactive Low normal Areactive van den Akker 2002 [29]”
BackgroundWei, J., Wei, J., Li, W., Yun-sheng, B., & Wei, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0153 · Cited by 44
Structural insights into the function of steroidogenic cytochrome P450 17A1
Yadav, R., Petrunak, E. M., Estrada, D. F., & Scott, E. E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.035 · Cited by 45
“As for the CYP17A1 half of the interface, early studies highlighted mutations of residues R347 and R358 in patients with selective 17,20-lyase deficiency and normal 17a-hydroxylation activity (Geller et al., 1997).”
BackgroundKurnaz, E., Baykan, E. K., Türkyılmaz, A., Yaralı, O., Abalı, Z. Y., Turan, S., Bereket, A., Çayır, A., & Güran, T. (2020) · Hormone Research in Paediatrics · doi:10.1159/000515079 · Cited by 48
Swart, A. C., Storbeck, K., & Swart, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.014 · Cited by 45
Metadata
- Authors
- Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Nature Genetics
- Published
- 1997-10
- Volume
- 17
- Issue
- 2
- Pages
- 201-205
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1995802297
- Semantic Scholar
- d93a35556fdab35e521babd17dc3e76db645439d
- Cited by
- 318
- References
- 31
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 4 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 11 · 2015: 16 · 2014: 14 · 2013: 16 · 2012: 7
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08dk002387-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, DK-02387, DK-0716, R01DK037922)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Keywords
- CYP17, P450c17, 17-hydroxylase deficiency, testosterone production, male sexual differentiation, substrate binding pocket, cytochrome P450 oxidoreductase, electrostatic charge distribution, substitution mutations
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Animals, Base Sequence, Binding Sites, Homozygote, Humans, Infant, Male, Models, Molecular, Mutation, Oxidation-Reduction, Protein Conformation, Steroid 17-alpha-Hydroxylase, Transfection, Polymerase Chain Reaction, DNA Primers, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.